Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Genta sales and marketing update

GNTA began selling Genasense oblimersen outside the U.S. on a named-patient basis, without restriction with regard to disease

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE